Baseline serum glycoprotein acetylation predicts early but not late relapse after infliximab withdrawal in Crohn's disease: metabolomic analysis of the STORI and SPARE trials

Gastroenterology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles